Systemic Lupus Erythematosus Clinical Trials

A listing of Systemic Lupus Erythematosus medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Contact LILAC Research Site Directly
Anniston Alabama 36207

A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects with Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects with Active Cutaneous Lupus Erythematosus with or without Systemic Manifestations.

Research Center
Anniston Alabama 36207

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

Anniston Alabama 36207

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Anniston Alabama 36207

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Birmingham Alabama 35294

A clinical study for patients with Systemic Lupus Erythematosus

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus

Birmingham Alabama 35294

A clinical trial to evaluate treatments using Brentuximab vedotin and Placebo for patients with Systemic Lupus Erythematosus

Birmingham Alabama 35216

A clinical trial to evaluate treatments using Placebo plus standard therapy, Belimumab 10 mg/kg plus standard therapy and Standard therapy for patients with Systemic Lupus Erythematosus

Birmingham Alabama

A Phase 2 clinical study for patients with Systemic Lupus Erythematosus (SLE)

Birmingham Alabama

A Phase 3 clinical study for patients with Active Systemic Lupus Erythematosus

Birmingham Alabama 35216

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Huntsville Alabama

A clinical research study of Ustekinumab, Placebo and Concomitant Medication for the treatment of Systemic Lupus Erythematosus

Huntsville Alabama 35801

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Arizona

Glendale Arizona 85304

A clinical study for patients with Systemic Lupus Erythematosus

Glendale Arizona 85306

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus

Glendale Arizona 85304

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Mesa Arizona 85202

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Phoenix Arizona 85032

A clinical study for patients with Systemic Lupus Erythematosus

View More ▼

Phoenix Arizona 85037

A clinical study for patients with Systemic Lupus Erythematosus

Phoenix Arizona 85032

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus

Phoenix Arizona 85032

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Phoenix Arizona 85037

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Phoenix Arizona 85032

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of belimumab 10mg/kg and placebo to evaluate Systemic Lupus Erythematosus

UPDATED

Tucson Arizona 85724

A clinical research study of Baricitinib and Placebo for the treatment of Systemic Lupus Erythematosus

Tucson Arizona 85724

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus

Arkansas

UPDATED

Little Rock Arkansas

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus

California

UPDATED

Contact LILAC Research Site Directly
La Mesa California 91942

A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects with Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects with Active Cutaneous Lupus Erythematosus with or without Systemic Manifestations.

Research Center
La Mesa California 91942

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

UPDATED

Contact LILAC Research Site Directly
Los Angeles California 90045

A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects with Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects with Active Cutaneous Lupus Erythematosus with or without Systemic Manifestations.

Research Center
Los Angeles California 90045

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

UPDATED

Contact LILAC Research Site Directly
Tustin California 92780

A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects with Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects with Active Cutaneous Lupus Erythematosus with or without Systemic Manifestations.

Research Center
Tustin California 92780

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

UPDATED

Contact LILAC Research Site Directly
Upland California 91786

A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects with Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects with Active Cutaneous Lupus Erythematosus with or without Systemic Manifestations.

UPDATED

Contact LILAC Research Site Directly
Upland California 91786

A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects with Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects with Active Cutaneous Lupus Erythematosus with or without Systemic Manifestations.

Research Center
Upland California 91786

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Upland California 91786

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
West Hills California 91307

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

Artesia California 90701

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus

Bakersfield California 93301

A clinical study for patients with Systemic Lupus Erythematosus

UPDATED

Beverly Hills California 90211

A clinical research study of Baricitinib and Placebo for the treatment of Systemic Lupus Erythematosus

UPDATED

Covina California 91723

A clinical research study of Baricitinib and Placebo for the treatment of Systemic Lupus Erythematosus

Covina California 91723

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Covina California

Patients are needed to participate in a clinical research study evaluating Anifrolumab and Placebo for the treatment of Active Systemic Lupus Erythematosus

UPDATED

El Cajon California 92020

A clinical research study of Baricitinib and Placebo for the treatment of Systemic Lupus Erythematosus

El Cajon California 92020

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus (SLE)

El Cajon California 92020-4124

A clinical trial to evaluate treatments using Brentuximab vedotin and Placebo for patients with Systemic Lupus Erythematosus

El Cajon California

A Phase 2 clinical study for patients with Systemic Lupus Erythematosus (SLE)

El Cajon California

A Phase 2 clinical study for patients with Systemic Lupus Erythematosus (SLE)

El Cajon California

A Phase 3 clinical study for patients with Active Systemic Lupus Erythematosus